Search Results

You are looking at 1 - 2 of 2 items for

  • Author: Martin Hirst x
  • Refine by access: All content x
Clear All Modify Search
Zahida Yesmin Roly Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Zahida Yesmin Roly in
Google Scholar
PubMed
Close
,
Andrew T Major Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Andrew T Major in
Google Scholar
PubMed
Close
,
Alex Fulcher Monash Micro Imaging, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Alex Fulcher in
Google Scholar
PubMed
Close
,
Martin A Estermann Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Martin A Estermann in
Google Scholar
PubMed
Close
,
Claire E Hirst Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Claire E Hirst in
Google Scholar
PubMed
Close
, and
Craig A Smith Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Craig A Smith in
Google Scholar
PubMed
Close

The embryonic Müllerian ducts give rise to the female reproductive tract (fallopian tubes, uterus and upper vagina in humans, the oviducts in birds). Embryonic Müllerian ducts initially develop in both sexes, but later regress in males under the influence of anti-Müllerian hormone. While the molecular and endocrine control of duct regression in males have been well studied, early development of the ducts in both sexes is less well understood. Here, we describe a novel role for the adhesion G protein-coupled receptor, GPR56, in development of the Müllerian ducts in the chicken embryo. GPR56 is expressed in the ducts of both sexes from early stages. The mRNA is present during the elongation phase of duct formation, and it is restricted to the inner Müllerian duct epithelium. The putative ligand, Collagen III, is abundantly expressed in the Müllerian duct at the same developmental stages. Knockdown of GPR56 expression using in ovo electroporation results in variably truncated ducts, with a loss of expression of both epithelial and mesenchymal markers of duct development. Over-expression of GPR56 in vitro results in enhanced cell proliferation and cell migration. These results show that GPR56 plays an essential role in avian Müllerian duct development through the regulation of duct elongation.

Restricted access
Celia Siu Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada
Department of Sciences, University of British Columbia, Vancouver, Canada

Search for other papers by Celia Siu in
Google Scholar
PubMed
Close
,
Sam Wiseman Department of Surgery, St. Paul’s Hospital & University of British Columbia, Vancouver, Canada

Search for other papers by Sam Wiseman in
Google Scholar
PubMed
Close
,
Sitanshu Gakkhar Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Sitanshu Gakkhar in
Google Scholar
PubMed
Close
,
Alireza Heravi-Moussavi Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Alireza Heravi-Moussavi in
Google Scholar
PubMed
Close
,
Misha Bilenky Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Misha Bilenky in
Google Scholar
PubMed
Close
,
Annaick Carles Department of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, Canada

Search for other papers by Annaick Carles in
Google Scholar
PubMed
Close
,
Thomas Sierocinski Department of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, Canada

Search for other papers by Thomas Sierocinski in
Google Scholar
PubMed
Close
,
Angela Tam Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Angela Tam in
Google Scholar
PubMed
Close
,
Eric Zhao Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Eric Zhao in
Google Scholar
PubMed
Close
,
Katayoon Kasaian Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Katayoon Kasaian in
Google Scholar
PubMed
Close
,
Richard A Moore Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Richard A Moore in
Google Scholar
PubMed
Close
,
Andrew J Mungall Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Search for other papers by Andrew J Mungall in
Google Scholar
PubMed
Close
,
Blair Walker Department of Pathology and Laboratory Medicine, St. Paul’s Hospital & University of British Columbia, Vancouver, Canada

Search for other papers by Blair Walker in
Google Scholar
PubMed
Close
,
Thomas Thomson Department of Pathology and Laboratory Medicine, BC Cancer Agency & University of British Columbia, Vancouver, Canada

Search for other papers by Thomas Thomson in
Google Scholar
PubMed
Close
,
Marco A Marra Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada
Department of Medical Genetics, University of British Columbia, Vancouver, Canada

Search for other papers by Marco A Marra in
Google Scholar
PubMed
Close
,
Martin Hirst Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada
Department of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, Canada

Search for other papers by Martin Hirst in
Google Scholar
PubMed
Close
, and
Steven J M Jones Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada
Department of Medical Genetics, University of British Columbia, Vancouver, Canada
Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, Canada

Search for other papers by Steven J M Jones in
Google Scholar
PubMed
Close

The thyroid gland, necessary for normal human growth and development, functions as an essential regulator of metabolism by the production and secretion of appropriate levels of thyroid hormone. However, assessment of abnormal thyroid function may be challenging suggesting a more fundamental understanding of normal function is needed. One way to characterize normal gland function is to study the epigenome and resulting transcriptome within its constituent cells. This study generates the first published reference epigenomes for human thyroid from four individuals using ChIP-seq and RNA-seq. We profiled six histone modifications (H3K4me1, H3K4me3, H3K27ac, H3K36me3, H3K9me3, H3K27me3), identified chromatin states using a hidden Markov model, produced a novel quantitative metric for model selection and established epigenomic maps of 19 chromatin states. We found that epigenetic features characterizing promoters and transcription elongation tend to be more consistent than regions characterizing enhancers or Polycomb-repressed regions and that epigenetically active genes consistent across all epigenomes tend to have higher expression than those not marked as epigenetically active in all epigenomes. We also identified a set of 18 genes epigenetically active and consistently expressed in the thyroid that are likely highly relevant to thyroid function. Altogether, these epigenomes represent a powerful resource to develop a deeper understanding of the underlying molecular biology of thyroid function and provide contextual information of thyroid and human epigenomic data for comparison and integration into future studies.

Free access